128 related articles for article (PubMed ID: 35618039)
1. Adenosine kinase (ADK) inhibition with ABT-702 induces ADK protein degradation and a distinct form of sustained cardioprotection.
Wölkart G; Stessel H; Fassett E; Teschl E; Friedl K; Trummer M; Schrammel A; Kollau A; Mayer B; Fassett J
Eur J Pharmacol; 2022 Jul; 927():175050. PubMed ID: 35618039
[TBL] [Abstract][Full Text] [Related]
2. Adenosine kinase inhibition protects against cisplatin-induced nephrotoxicity.
Cao W; Yuan Y; Liu X; Li Q; An X; Huang Z; Wu L; Zhang B; Zhang A; Xing C
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F107-F115. PubMed ID: 30995110
[TBL] [Abstract][Full Text] [Related]
3. Adenosine kinase inhibition attenuates ischemia reperfusion-induced acute kidney injury.
Cao W; Wan H; Wu L; An X; Li Q; Dong J; Duan S; Huang Z; Zhang B; Xing C; Yuan Y
Life Sci; 2020 Sep; 256():117972. PubMed ID: 32544464
[TBL] [Abstract][Full Text] [Related]
4. Adenosine kinase inhibition enhances microvascular dilator function and improves left ventricle diastolic dysfunction.
Davila A; Tian Y; Czikora I; S Weissman A; Weinand N; Dong G; Xu J; Li J; Su H; Kapuku G; Huo Y; Bagi Z
Microcirculation; 2020 Aug; 27(6):e12624. PubMed ID: 32352607
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury.
Wang W; Wang B; Sun S; Cao S; Zhai X; Zhang C; Zhang Q; Yuan Q; Sun Y; Xue M; Ma J; Xu F; Wei S; Chen Y
J Cell Mol Med; 2021 Mar; 25(6):2931-2943. PubMed ID: 33523568
[TBL] [Abstract][Full Text] [Related]
6. Adenosine Kinase Inhibition Augments Conducted Vasodilation and Prevents Left Ventricle Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
Davila A; Tian Y; Czikora I; Li J; Su H; Huo Y; Patel V; Robinson V; Kapuku G; Weintraub N; Bagi Z
Circ Heart Fail; 2019 Aug; 12(8):e005762. PubMed ID: 31525084
[TBL] [Abstract][Full Text] [Related]
7. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholinopyridin-3-yl)pyrido[2, 3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties: I. In vitro characterization and acute antinociceptive effects in the mouse.
Jarvis MF; Yu H; Kohlhaas K; Alexander K; Lee CH; Jiang M; Bhagwat SS; Williams M; Kowaluk EA
J Pharmacol Exp Ther; 2000 Dec; 295(3):1156-64. PubMed ID: 11082453
[TBL] [Abstract][Full Text] [Related]
8. The adenosine kinase inhibitor ABT-702 augments EEG slow waves in rats.
Radek RJ; Decker MW; Jarvis MF
Brain Res; 2004 Nov; 1026(1):74-83. PubMed ID: 15476699
[TBL] [Abstract][Full Text] [Related]
9. Adenosine kinase attenuates cardiomyocyte microtubule stabilization and protects against pressure overload-induced hypertrophy and LV dysfunction.
Fassett J; Xu X; Kwak D; Zhu G; Fassett EK; Zhang P; Wang H; Mayer B; Bache RJ; Chen Y
J Mol Cell Cardiol; 2019 May; 130():49-58. PubMed ID: 30910669
[TBL] [Abstract][Full Text] [Related]
10. A hypoxic episode during cardiogenesis downregulates the adenosinergic system and alters the myocardial anoxic tolerance.
Robin E; Marcillac F; Raddatz E
Am J Physiol Regul Integr Comp Physiol; 2015 Apr; 308(7):R614-26. PubMed ID: 25632022
[TBL] [Abstract][Full Text] [Related]
11. Adenosine-mediated cardioprotection in ischemic-reperfused mouse heart.
Peart J; Flood A; Linden J; Matherne GP; Headrick JP
J Cardiovasc Pharmacol; 2002 Jan; 39(1):117-29. PubMed ID: 11743234
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
Bradamante S; Barenghi L; Piccinini F; Bertelli AA; De Jonge R; Beemster P; De Jong JW
Eur J Pharmacol; 2003 Mar; 465(1-2):115-23. PubMed ID: 12650840
[TBL] [Abstract][Full Text] [Related]
13. An interaction between glucagon-like peptide-1 and adenosine contributes to cardioprotection of a dipeptidyl peptidase 4 inhibitor from myocardial ischemia-reperfusion injury.
Ihara M; Asanuma H; Yamazaki S; Kato H; Asano Y; Shinozaki Y; Mori H; Minamino T; Asakura M; Sugimachi M; Mochizuki N; Kitakaze M
Am J Physiol Heart Circ Physiol; 2015 May; 308(10):H1287-97. PubMed ID: 25747753
[TBL] [Abstract][Full Text] [Related]
14. ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy.
Elsherbiny NM; Ahmad S; Naime M; Elsherbini AM; Fulzele S; Al-Gayyar MM; Eissa LA; El-Shishtawy MM; Liou GI
Life Sci; 2013 Jul; 93(2-3):78-88. PubMed ID: 23770229
[TBL] [Abstract][Full Text] [Related]
15. Consecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioning.
Khaliulin I; Parker JE; Halestrap AP
Cardiovasc Res; 2010 Nov; 88(2):324-33. PubMed ID: 20558443
[TBL] [Abstract][Full Text] [Related]
16. ABT-702 (4-amino-5-(3-bromophenyl)-7-(6-morpholino-pyridin- 3-yl)pyrido[2,3-d]pyrimidine), a novel orally effective adenosine kinase inhibitor with analgesic and anti-inflammatory properties. II. In vivo characterization in the rat.
Kowaluk EA; Mikusa J; Wismer CT; Zhu CZ; Schweitzer E; Lynch JJ; Lee CH; Jiang M; Bhagwat SS; Gomtsyan A; McKie J; Cox BF; Polakowski J; Reinhart G; Williams M; Jarvis MF
J Pharmacol Exp Ther; 2000 Dec; 295(3):1165-74. PubMed ID: 11082454
[TBL] [Abstract][Full Text] [Related]
17. Role of adenosine kinase in cochlear development and response to noise.
Vlajkovic SM; Guo CX; Dharmawardana N; Wong AC; Boison D; Housley GD; Thorne PR
J Neurosci Res; 2010 Sep; 88(12):2598-609. PubMed ID: 20648650
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Zhao T; Xi L; Chelliah J; Levasseur JE; Kukreja RC
Circulation; 2000 Aug; 102(8):902-7. PubMed ID: 10952960
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart.
Peart J; Matherne GP; Cerniway RJ; Headrick JP
Cardiovasc Res; 2001 Oct; 52(1):120-9. PubMed ID: 11557240
[TBL] [Abstract][Full Text] [Related]
20. An adenosine kinase inhibitor, ABT-702, inhibits spinal nociceptive transmission by adenosine release via equilibrative nucleoside transporters in rat.
Otsuguro K; Tomonari Y; Otsuka S; Yamaguchi S; Kon Y; Ito S
Neuropharmacology; 2015 Oct; 97():160-70. PubMed ID: 26066576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
